ArticleCancer2015

Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma.

William W Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.